I popped along to the Master Investor in focus: Investing in European Cannabis & CBD Market on Thursday.
Listened to Jonathan Deverill speaking at the event around the legality of cannabis, and the amount of companies popping up in far flung places all over the world.
There were also other speakers from the medical sector, and I believe a representative of the Canadian Securities Exchange.
My brief summary would be as follows:
Rules are changing fast, some companies could be exposing themselves to pitfalls they are not aware of yet, and may have overreaching targets, or could come up against legislation that impacts their growth ambitions accordingly.
But one thing is clear, there is a lot of money to be made in this sector. The use cases and applications for CBD are growing far quicker than the plants themselves, which are needed to feed the market, although that in itself won’t last forever.
Getting in early and establishing yourself as a vertically integrated business is key, and Highlands Natural Resources appears to be doing just that.
It is important to ensure that who you invest in, has been advised correctly and keeps an eye on what’s down the road.
It was great to hear him (Jonathan) give a shout out (twice) to Highlands, by being listed on the London Main Market, and a company which, he importantly, has advised.
Robert Price (CEO of Highlands), who was in the audience, then gave a brief summary of Highlands being based in Colorado, but listed in the UK, and importantly being a vertically integrated CBD business, which seemed well received.
I’ve mentioned this simply because of some of the earlier very misguided posts being made on the LSE chat boards around HNR’s market being so restrictive, and stupid comments like “peddling CBD from a shed to 18 garages” and so on.
Whilst there are clearly some legal challenges and restrictions in the sector still, both in some individual US States and various Countries, it is very good to know HNR have sought expert and specialist legal advice.
When talking about investing in the market and hearing the obvious names, it was great to hear Highlands mentioned in amongst the big boys.
Of course it wasn’t advice to invest in them directly, nor an endorsement as such, but still...
Individually highlighting the fact that Highlands is there on the UK Main Market, as a well advised company who have done their homework, and as a vertically integrated CBD business was good to hear.
Shame the chair couldn’t bring himself to add to Jonathan’s shout out for Highlands in his follow up written article (link above) but still, It’s all good.